CFDE Data Portal | Search ATXN7

	Label	Description
	ATXN7 associations Collection (Entity type)	Associations for ATXN7_associations
	ATXN7 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	ATXN7 Gene (Entity type)	ENSG00000163635 - ataxin 7
	KFGENEBIN:ATXN7-variant-count CUI gene has variants ATXN7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE226285 3 V 0 GLUTATHIONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE242290 3 V 2 GLUTATHIONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225869 3 V 0 TEMOZOLOMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE114883 0 V 5 ROMIDEPSIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE234647 1 V 3 REGORAFENIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

ATXN7 associations

Associations for ATXN7_associations

ATXN7 associations.tsv

A file from IDG as part of the Harmonizome project

ATXN7

ENSG00000163635 - ataxin 7

KFGENEBIN:ATXN7-variant-count CUI gene has variants ATXN7

A Knowledge Graph Assertion from Kids First

GSE226285 3 V 0 GLUTATHIONE HUMAN UP

A Gene Set from LINCS

GSE242290 3 V 2 GLUTATHIONE HUMAN DN

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 3 v 1 human dn

A Gene Set from LINCS

GSE225869 3 V 0 TEMOZOLOMIDE HUMAN UP

A Gene Set from LINCS

GSE114883 0 V 5 ROMIDEPSIN HUMAN DN

A Gene Set from LINCS

GSE234647 1 V 3 REGORAFENIB HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.